Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
simethicone, Quantity: 125 mg; loperamide hydrochloride, Quantity: 2 mg
Johnson & Johnson Pacific Pty Ltd
Loperamide hydrochloride,Simethicone
Tablet, chewable
Excipient Ingredients: hypromellose; stearic acid; magnesium carbonate hydrate; acesulfame potassium; povidone; glucose monohydrate; silicon dioxide; calcium phosphate; xylitol; carmellose sodium; Flavour
Oral
6, 12
Not scheduled. Not considered by committee, (S2) Pharmacy Medicine
Treatment of acute diarrhoea with associated gas-related abdominal discomfort.
Visual Identification: 15.9mm diameter round bevel edged, white to off white,slightly mottled,uncoated, chewable tablet; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2015-04-07